Development of Insomnia Associated With Different Formulations of Bupropion

Kamal Gandotra; George E Jaskiw; Scott G Williams; Matthew A Fuller; Peijun Chen; Brigid Wilson; Rawad ElGhoul; Eric Konicki; Kingman Perkins Strohl

doi:10.4088/PCC.20br02621

Development of Insomnia Associated With Different Formulations of Bupropion

Prim Care Companion CNS Disord. 2021 Feb 18;23(1):20br02621. doi: 10.4088/PCC.20br02621.

Authors

Kamal Gandotra^{1

2

3

4

5}, George E Jaskiw^{2

3}, Scott G Williams^{6

7}, Matthew A Fuller^{8

9}, Peijun Chen^{2

3}, Brigid Wilson¹⁰, Rawad ElGhoul⁴, Eric Konicki^{2

3}, Kingman Perkins Strohl^{4

11}

Affiliations

¹ Louis Stokes VA Medical Center, Cleveland, Ohio.
² Psychiatry Service, Louis Stokes VA Medical Center, Cleveland, Ohio.
³ Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio.
⁴ Division of Pulmonary, Critical Care, and Sleep Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio.
⁵ Corresponding author: Kamal Gandotra, MD, Louis Stokes VAMC, 10701 East Blvd, Cleveland, OH 44106 ([email protected]).
⁶ Sleep Disorders Center, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland.
⁷ Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda.
⁸ National PBM Clinical Pharmacy Program Manager VHA Pharmacy Benefits Management Services, Hines, Illinois.
⁹ Departments of Psychiatry and Psychology, Case Western Reserve University, Cleveland, Ohio.
¹⁰ Geriatric Research Educational and Clinical Center (GRECC), Louis Stokes VA Medical Center, Cleveland, Ohio.
¹¹ Division of Pulmonary, Critical Care and Sleep Medicine, University Hospitals, Case Western Reserve University, Cleveland, Ohio.

PMID: 34000136
DOI: 10.4088/PCC.20br02621

No abstract available

MeSH terms

Antidepressive Agents, Second-Generation* / adverse effects
Bupropion / adverse effects
Delayed-Action Preparations / therapeutic use
Depressive Disorder, Major* / drug therapy
Humans
Sleep Initiation and Maintenance Disorders* / chemically induced
Sleep Initiation and Maintenance Disorders* / complications
Sleep Initiation and Maintenance Disorders* / drug therapy

Substances

Antidepressive Agents, Second-Generation
Delayed-Action Preparations
Bupropion